Lipid control in the modern era: an orphan's tale of rags to riches

J Am Coll Cardiol. 2013 Dec 10;62(23):2185-7. doi: 10.1016/j.jacc.2013.07.083. Epub 2013 Sep 4.

Authors

Richard V Milani¹, Carl J Lavie

Affiliation

¹ Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-University of Queensland School of Medicine, New Orleans, Louisiana. Electronic address: rmilani@ochsner.org.

PMID: 24013061
DOI: 10.1016/j.jacc.2013.07.083

No abstract available

Keywords: antisense oligonucleotides; apolipoprotein B; cholesterol inhibitors; hypolipidemic agents; lipid-regulating agents.

Publication types

Editorial
Comment

MeSH terms

Anticholesteremic Agents / therapeutic use*
Apolipoproteins B / antagonists & inhibitors*
Atherosclerosis / prevention & control*
Cardiovascular Diseases / prevention & control*
Cholesterol, LDL / blood*
Female
Humans
Hypercholesterolemia / drug therapy*
Male
Oligonucleotides / therapeutic use*

Substances

Anticholesteremic Agents
Apolipoproteins B
Cholesterol, LDL
Oligonucleotides
mipomersen